Biotron Ltd
ASX:BIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotron Ltd
ASX:BIT
|
AU |
|
Ramayana Lestari Sentosa Tbk PT
IDX:RALS
|
ID |
|
Experience Co Ltd
ASX:EXP
|
AU |
|
Bourse Direct SA
F:BD6
|
FR |
|
Techno Electric & Engineering Company Ltd
NSE:TECHNOE
|
IN |
|
TransUnion
NYSE:TRU
|
US |
|
Intiland Development Tbk PT
F:DIIA
|
ID |
|
A
|
Arena Pharmaceuticals Inc
F:RN3N
|
US |
|
Nova Eye Medical Ltd
ASX:EYE
|
AU |
|
Starpharma Holdings Ltd
ASX:SPL
|
AU |
|
B
|
B'IN Live Co Ltd
TWSE:6625
|
TW |
|
Sharp Corp
TSE:6753
|
JP |
|
Eco Atlantic Oil & Gas Ltd
XTSX:EOG
|
CA |
|
Gyldendal ASA
OSE:GYL
|
NO |
|
CareDx Inc
NASDAQ:CDNA
|
US |
|
B
|
Bear Creek Mining Corp
XTSX:BCM
|
CA |
|
NK Russneft' PAO
MOEX:RNFT
|
RU |
|
G
|
Grande Asset Hotels and Property PCL
SET:GRAND
|
TH |
Balance Sheet
Balance Sheet Decomposition
Biotron Ltd
Biotron Ltd
Balance Sheet
Biotron Ltd
| Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
8
|
5
|
3
|
2
|
5
|
1
|
2
|
1
|
2
|
2
|
8
|
5
|
2
|
5
|
3
|
2
|
2
|
6
|
8
|
4
|
2
|
4
|
0
|
1
|
|
| Cash |
8
|
5
|
3
|
2
|
5
|
1
|
2
|
1
|
2
|
2
|
8
|
5
|
2
|
5
|
3
|
2
|
2
|
6
|
8
|
4
|
2
|
4
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
8
|
6
|
3
|
2
|
5
|
1
|
2
|
1
|
2
|
3
|
8
|
5
|
2
|
5
|
3
|
2
|
2
|
6
|
8
|
4
|
2
|
4
|
0
|
1
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
6
-32%
|
3
-47%
|
2
-22%
|
5
+98%
|
2
-68%
|
2
+49%
|
1
-53%
|
2
+75%
|
3
+42%
|
8
+220%
|
5
-42%
|
2
-62%
|
5
+148%
|
3
-25%
|
2
-41%
|
2
-21%
|
6
+262%
|
8
+34%
|
4
-45%
|
2
-56%
|
4
+117%
|
0
-88%
|
1
+99%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+7%
|
0
N/A
|
0
N/A
|
0
+113%
|
0
-50%
|
0
+163%
|
0
-48%
|
0
-36%
|
0
+71%
|
0
-21%
|
0
+105%
|
0
+21%
|
0
+1%
|
0
-27%
|
1
+79%
|
0
-45%
|
0
+24%
|
1
+104%
|
0
-46%
|
1
+76%
|
1
+18%
|
1
-23%
|
0
-42%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
11
|
11
|
11
|
13
|
17
|
17
|
19
|
20
|
21
|
23
|
33
|
33
|
33
|
37
|
39
|
40
|
41
|
48
|
53
|
53
|
53
|
57
|
57
|
59
|
|
| Retained Earnings |
3
|
6
|
8
|
10
|
12
|
16
|
17
|
19
|
19
|
21
|
24
|
28
|
31
|
33
|
36
|
39
|
40
|
42
|
46
|
49
|
52
|
55
|
59
|
59
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
|
| Total Equity |
8
N/A
|
6
-32%
|
3
-49%
|
2
-23%
|
5
+97%
|
1
-70%
|
2
+35%
|
1
-54%
|
2
+105%
|
2
+40%
|
8
+245%
|
4
-46%
|
1
-69%
|
4
+198%
|
3
-24%
|
1
-54%
|
1
-11%
|
5
+324%
|
7
+28%
|
4
-45%
|
1
-72%
|
3
+190%
|
0
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
9
N/A
|
6
-32%
|
3
-47%
|
2
-22%
|
5
+98%
|
2
-68%
|
2
+49%
|
1
-53%
|
2
+74%
|
3
+42%
|
8
+220%
|
5
-42%
|
2
-62%
|
5
+148%
|
3
-25%
|
2
-41%
|
2
-21%
|
6
+262%
|
8
+34%
|
4
-45%
|
2
-56%
|
4
+117%
|
0
-88%
|
1
+99%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
82
|
82
|
82
|
86
|
110
|
110
|
129
|
141
|
150
|
182
|
281
|
281
|
281
|
343
|
363
|
447
|
519
|
615
|
725
|
725
|
828
|
1 031
|
1 031
|
1 327
|
|